Indoco Remedies reported 14.84% growth in total revenues for the Dec-20 quarter on consolidated basis at Rs332.29cr. While the India revenues of Indoco were lower on a yoy basis during the Dec-20 quarter, the global revenues were up nearly 60% on a yoy basis and that more than made up for the slowdown in domestic sales.
The consolidated Profit after tax (PAT) for the Dec-20 quarter was up 178.68% at Rs25.36cr. While there was a spike in the cost of materials, the company more than made up through tweaking the inventories to reduce the amount locked up in the working capital cycle. As a result, the PAT margins more than doubled from 3.14% in Dec-19 to 7.63% in Dec-20.
Financial highlights for Dec-20 compared yoy and sequentially
|
|
Indoco Remedies |
|
|
|
|
|
Rs in Crore |
Dec-20 |
Dec-19 |
YOY |
Sep-20 |
QOQ |
|
Total Income (Rs cr) |
₹ 332.29 |
₹ 289.35 |
14.84% |
₹ 328.24 |
1.23% |
|
Net Profit (Rs cr) |
₹ 25.36 |
₹ 9.10 |
178.68% |
₹ 25.65 |
-1.13% |
|
|
|
|
|
|
|
|
Diluted EPS (Rs) |
₹ 2.75 |
₹ 0.99 |
|
₹ 2.78 |
|
|
Net Margins |
7.63% |
3.14% |
|
7.81% |
|
Related Tags: